Ramaswamy SB and Govindarajan R. J Neuromuscul Dis 2020.
ABSTRACT
This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.
PMID:32508329 | DOI:10.3233/JND-200520
Source: https://pubmed.ncbi.nlm.nih.gov/3250832 ... 19&v=2.8.0
